Retinal microglia: just bystander or target for therapy?

This work was supported by the DFG (LA1203/6-2 and LA1203/ 8-1), the Hans und Marlies Stock-Foundation, the Pro Retina Foundation, the Novartis EYEnovative Program, and the Bayer Graduate Program in Pharmacology.